{
  "abstract": "Background: Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP) has become a first-line treatment option for diffuse large B-cell lymphoma (DLBCL), but real-world data remain limited. We retrospectively compared Pola-R-CHP and R-CHOP in patients with newly diagnosed DLBCL. Methods: We analyzed 127 patients who received first-line Pola-R-CHP (n = 57) or R-CHOP (n = 70) at a single center between January 2021 and August 2025. The primary endpoint was progression-free survival (PFS). Secondary endpoints included overall survival (OS) and adverse events. A 120-day landmark analysis, subgroup analyses, and exploratory analysis for sepsis were also performed. Results: Median age was 75 years in the Pola-R-CHP group and 79.5 years in the R-CHOP group; patients aged >80 years were more frequent in the R-CHOP group (21.1% vs 47.1%, P = 0.003). 1-year PFS was 83.9% with Pola-R-CHP and 76.9% with R-CHOP (P = 0.56). 1-year OS was 89.8% and 91.1%, respectively (P = 0.61). In the 120-day landmark analysis, no significant difference in PFS was observed (HR 0.68, 95% CI 0.29–1.56, P = 0.36). Infection-related treatment discontinuation was more frequent with Pola-R-CHP (12.3% vs 0%, P = 0.003). Sepsis was also more frequent in the Pola-R-CHP group (14.0% vs 4.3%, P = 0.098). Conclusions: In this single-center retrospective cohort, Pola-R-CHP was not associated with a significant improvement in PFS compared with R-CHOP. Infection-related treatment discontinuation was more frequent in the Pola-R-CHP group. Sepsis was also numerically more frequent, highlighting the importance of careful infection monitoring in clinical practice.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Hematology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan, Department of Pathology, Yokosuka Kyosai Hospital, Yokosuka, Kanagawa, Japan, Department of Pathology, Tokai university school of medicine, Isehara, Kanagawa, Japan"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Kaori Akita"
    },
    {
      "affs": [
        0
      ],
      "name": "Atsushi Takahata"
    },
    {
      "affs": [
        0
      ],
      "name": "Wataru Tokuyama"
    },
    {
      "affs": [
        0
      ],
      "name": "Naoya Nakamura"
    },
    {
      "affs": [
        0
      ],
      "name": "Shigeo Toyota"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2pyymqbgfk1q8.bib",
  "cited_by": 1,
  "doi": "10.3960/jslrt.26017",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759255/",
  "id": "2pyymqbgfk1q8",
  "issns": [
    "1346-4280",
    "1880-9952"
  ],
  "landing_url": "https://doi.org/10.3960/jslrt.26017",
  "language": "en",
  "licence": "CC-BY-NC-SA-4.0",
  "licence_label": "CC BY-NC-SA 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Article"
    ],
    [
      "openalex",
      "2734|Lymphoma Diagnosis and Treatment"
    ]
  ],
  "openalex": "W7171728962",
  "pdf_url": "https://www.jstage.jst.go.jp/article/jslrt/advpub/0/advpub_26017/_pdf",
  "pmcid": "PMC13759255",
  "pmid": "42528233",
  "published": "2026-07-30",
  "publisher": "Japanese Society for Lymphoreticular Tissue Research",
  "ris": "https://research.draconitic.com/paper/2pyymqbgfk1q8.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:55Z",
      "native_id": "PMC13759255",
      "source": "pmc",
      "url": "https://doi.org/10.3960/jslrt.26017"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2734|Lymphoma Diagnosis and Treatment",
      "subfield": "general"
    }
  ],
  "title": "Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study",
  "title_text": "Comparison of Pola-R-CHP and R-CHOP for newly diagnosed DLBCL: A single-center retrospective study",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:55Z",
  "url": "https://research.draconitic.com/paper/2pyymqbgfk1q8",
  "venue": "Journal of Clinical and Experimental Hematopathology : JCEH",
  "versions": []
}